Results 351 to 360 of about 3,018,484 (379)
Some of the next articles are maybe not open access.
You can’t use this app for that: Exploring off-label use through an investigation of Tinder
The Information Society, 2019This article reconceptualizes the pharmacological term “off-label use” in the context of platforms and apps. It combines literature on technological appropriation with research on platforms’ sociotechnical arrangements to understand off-label use as ...
Stefanie Duguay
semanticscholar +1 more source
Off-label use of drugs in pediatrics: a scoping review
European Journal of Pediatrics, 2022M. Meng +15 more
semanticscholar +1 more source
Journal of Personality Disorders, 2019
The guidelines for borderline personality disorder (BPD) treatment suggest non-pharmacological treatment as the first option, but second-generation antipsychotics (SGAs) are among the overprescribed medications.
A. Aguglia +12 more
semanticscholar +1 more source
The guidelines for borderline personality disorder (BPD) treatment suggest non-pharmacological treatment as the first option, but second-generation antipsychotics (SGAs) are among the overprescribed medications.
A. Aguglia +12 more
semanticscholar +1 more source
„Off-label-use“ von Arzneimitteln
2008Das Arzneimittelrecht gehort zu den rechtlich am intensivsten regulierten Bereichen des Gesundheitswesens. Nicht zuletzt als Folge spektakularer Arzneimittelzwischenfalle („Contergan“) hat sich auf nationaler und europaischer Ebene ein umfassendes Regelwerk herausgebildet, das die Herstellung, das Inverkehrbringen und die Uberwachung von Arzneimitteln ...
openaire +2 more sources
Off-Label Use of Clozapine in Children and Adolescents—A Literature Review
American Journal of Therapeutics, 2019Background: Clozapine is a second-generation antipsychotic typically used for refractory schizophrenia or otherwise psychotic pathology. There are no FDA or manufacturer guidelines for use of clozapine in pediatric population. We investigated the current
Vivekananda Rachamallu +3 more
semanticscholar +1 more source
Food and drug law journal, 2009
In this study, the authors examine factors underlying payer off-label use reimbursement policies. Updating a study published 14 years ago, presenting the results of the survey of 179 payers administering public (Medicare and Medicaid) pharmacy benefits.
Joshua, Cohen +2 more
openaire +1 more source
In this study, the authors examine factors underlying payer off-label use reimbursement policies. Updating a study published 14 years ago, presenting the results of the survey of 179 payers administering public (Medicare and Medicaid) pharmacy benefits.
Joshua, Cohen +2 more
openaire +1 more source
Journal of American Academy of Dermatology, 2020
Sean Igelman +20 more
semanticscholar +1 more source
Sean Igelman +20 more
semanticscholar +1 more source